|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Eidos Therapeutics, Inc. (EIDX) |
|
|
$122.21 0.00 (0.00%) as of 4:30 Mon 1/25
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
38,660,000 |
| Market
Cap: |
4.72(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$122.21 - $122.21 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Turtle Cameron |
Chief Business Officer |
• – – |
2019-06-04 |
4 |
S |
$31.33 |
$316,402 |
D/D |
(10,000) |
100,155 |
|
- |
|
| Sinha Uma |
Chief Scientific Officer |
• – – |
2019-05-31 |
4 |
A |
$12.01 |
$21,247 |
D/D |
1,769 |
351,081 |
|
- |
|
| Fox Jonathan C |
See Remarks |
• – – |
2019-05-31 |
4 |
A |
$12.01 |
$21,247 |
D/D |
1,769 |
2,850 |
|
- |
|
| Siu Christine |
CFO and Secretary |
• – – |
2019-05-31 |
4 |
A |
$12.01 |
$21,247 |
D/D |
1,769 |
36,470 |
|
- |
|
| Turtle Cameron |
Chief Business Officer |
• – – |
2019-05-31 |
4 |
A |
$12.01 |
$21,246 |
D/D |
1,769 |
110,155 |
|
- |
|
| Fox Jonathan C |
See Remarks |
• – – |
2019-05-30 |
4 |
S |
$32.64 |
$163,179 |
I/I |
(5,000) |
516,527 |
|
- |
|
| Bridgebio Pharma Llc |
10% Owner |
– – • |
2019-05-24 |
4 |
B |
$25.93 |
$28,622,779 |
D/D |
1,103,848 |
23,693,148 |
2.45 |
- |
|
| Satvat Ali J. |
Director |
– • • |
2019-05-24 |
4 |
B |
$25.93 |
$28,622,779 |
I/I |
1,103,848 |
23,693,148 |
2.25 |
- |
|
| Kumar Neil |
Chief Executive Officer |
• • • |
2019-05-24 |
4 |
B |
$25.93 |
$28,622,779 |
I/I |
1,103,848 |
23,693,148 |
2.64 |
- |
|
| Aguiar Eric |
Director |
– • • |
2019-05-24 |
4 |
B |
$25.93 |
$28,622,779 |
I/I |
1,103,848 |
23,693,148 |
2.25 |
- |
|
| Sinha Uma |
Chief Scientific Officer |
• – – |
2019-05-23 |
4 |
S |
$27.16 |
$136,376 |
D/D |
(5,000) |
349,312 |
|
- |
|
| Fox Jonathan C |
See Remarks |
• – – |
2019-05-03 |
4 |
S |
$25.03 |
$125,150 |
I/I |
(5,000) |
521,527 |
|
- |
|
| Fox Jonathan C |
See Remarks |
• – – |
2019-05-01 |
4 |
S |
$25.30 |
$127,287 |
I/I |
(5,000) |
526,527 |
|
- |
|
| Fox Jonathan C |
See Remarks |
• – – |
2019-04-15 |
4 |
S |
$23.11 |
$115,550 |
I/I |
(5,000) |
531,527 |
|
- |
|
| Siu Christine |
CFO and Secretary |
• – – |
2019-03-19 |
4 |
S |
$19.66 |
$234,210 |
D/D |
(11,913) |
34,701 |
|
- |
|
| Siu Christine |
CFO and Secretary |
• – – |
2019-03-19 |
4 |
OE |
$0.15 |
$22,081 |
D/D |
45,533 |
46,614 |
|
- |
|
| Bridgebio Pharma Llc |
10% Owner |
– – • |
2018-12-10 |
4/A |
B |
$13.29 |
$542,063 |
D/D |
40,653 |
22,589,300 |
2.45 |
- |
|
| Bridgebio Pharma Llc |
10% Owner |
– – • |
2018-12-10 |
4 |
S |
$13.29 |
$542,063 |
D/D |
(40,653) |
22,589,300 |
|
- |
|
| Bridgebio Pharma Llc |
10% Owner |
– – • |
2018-12-07 |
4/A |
B |
$13.94 |
$576,007 |
D/D |
41,174 |
22,548,647 |
2.45 |
- |
|
| Bridgebio Pharma Llc |
10% Owner |
– – • |
2018-12-07 |
4 |
S |
$13.94 |
$576,007 |
D/D |
(41,174) |
22,548,647 |
|
- |
|
| Bridgebio Pharma Llc |
10% Owner |
– – • |
2018-12-06 |
4/A |
B |
$13.34 |
$519,860 |
D/D |
38,970 |
22,507,473 |
2.45 |
- |
|
| Bridgebio Pharma Llc |
10% Owner |
– – • |
2018-12-06 |
4 |
S |
$13.34 |
$519,860 |
D/D |
(38,970) |
22,507,473 |
|
- |
|
| Bridgebio Pharma Llc |
10% Owner |
– – • |
2018-12-05 |
4 |
B |
$14.01 |
$15,464,910 |
D/D |
1,103,848 |
22,468,503 |
2.45 |
- |
|
| Bridgebio Pharma Llc |
10% Owner |
– – • |
2018-12-03 |
4 |
B |
$15.50 |
$27,125,000 |
D/D |
1,750,000 |
21,364,655 |
2.45 |
- |
|
| Turtle Cameron |
Chief Business Officer |
• – – |
2018-11-30 |
4 |
A |
$12.01 |
$12,983 |
D/D |
1,081 |
108,386 |
|
- |
|
141 Records found
|
|
Page 5 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
